Hepatocellular carcinoma: New options for image-guided ablation

Riccardo Lencioni, Dania Cioni, Clotilde Della Pina, Laura Crocetti

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Image-guided percutaneous ablation is currently accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when transplantation and resection are precluded. Several methods for chemical or thermal tumor destruction have been developed and tested clinically during the past two decades. The seminal technique used for local treatment of HCC has been percutaneous ethanol injection (PEI). Several studies have provided indirect evidence that PEI improves the natural history of nonsurgical patients with early-stage HCC. Its major limitation is the high rate of local recurrence. Radiofrequency (RF) ablation has been the most widely assessed alternative to PEI. Five randomized controlled trials have shown that RF ablation achieves more effective and reproducible tumor destruction than PEI, leading to a better local control of the disease. As a result, RF ablation has been established as the primary ablative modality. The value of newer thermal and nonthermal methods for local tumor treatment, such as microwave ablation, irreversible electroporation (IRE), and light activated drug therapy, should be investigated in the setting of randomized controlled trials.

Original languageEnglish (US)
Pages (from-to)399-403
Number of pages5
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume17
Issue number4
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Ethanol
Injections
Randomized Controlled Trials
Incineration
Neoplasms
Electroporation
Microwaves
Natural History
Therapeutics
Hot Temperature
Transplantation
Light
Recurrence
Drug Therapy

Keywords

  • Hepatocellular carcinoma
  • Percutaneous ethanol injection
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Medicine(all)
  • Hepatology
  • Surgery

Cite this

Hepatocellular carcinoma : New options for image-guided ablation. / Lencioni, Riccardo; Cioni, Dania; Della Pina, Clotilde; Crocetti, Laura.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 17, No. 4, 07.2010, p. 399-403.

Research output: Contribution to journalArticle

Lencioni, Riccardo ; Cioni, Dania ; Della Pina, Clotilde ; Crocetti, Laura. / Hepatocellular carcinoma : New options for image-guided ablation. In: Journal of Hepato-Biliary-Pancreatic Sciences. 2010 ; Vol. 17, No. 4. pp. 399-403.
@article{04f19044e97d44bc89570b92c6cd6527,
title = "Hepatocellular carcinoma: New options for image-guided ablation",
abstract = "Image-guided percutaneous ablation is currently accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when transplantation and resection are precluded. Several methods for chemical or thermal tumor destruction have been developed and tested clinically during the past two decades. The seminal technique used for local treatment of HCC has been percutaneous ethanol injection (PEI). Several studies have provided indirect evidence that PEI improves the natural history of nonsurgical patients with early-stage HCC. Its major limitation is the high rate of local recurrence. Radiofrequency (RF) ablation has been the most widely assessed alternative to PEI. Five randomized controlled trials have shown that RF ablation achieves more effective and reproducible tumor destruction than PEI, leading to a better local control of the disease. As a result, RF ablation has been established as the primary ablative modality. The value of newer thermal and nonthermal methods for local tumor treatment, such as microwave ablation, irreversible electroporation (IRE), and light activated drug therapy, should be investigated in the setting of randomized controlled trials.",
keywords = "Hepatocellular carcinoma, Percutaneous ethanol injection, Radiofrequency ablation",
author = "Riccardo Lencioni and Dania Cioni and {Della Pina}, Clotilde and Laura Crocetti",
year = "2010",
month = "7",
doi = "10.1007/s00534-009-0233-0",
language = "English (US)",
volume = "17",
pages = "399--403",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Hepatocellular carcinoma

T2 - New options for image-guided ablation

AU - Lencioni, Riccardo

AU - Cioni, Dania

AU - Della Pina, Clotilde

AU - Crocetti, Laura

PY - 2010/7

Y1 - 2010/7

N2 - Image-guided percutaneous ablation is currently accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when transplantation and resection are precluded. Several methods for chemical or thermal tumor destruction have been developed and tested clinically during the past two decades. The seminal technique used for local treatment of HCC has been percutaneous ethanol injection (PEI). Several studies have provided indirect evidence that PEI improves the natural history of nonsurgical patients with early-stage HCC. Its major limitation is the high rate of local recurrence. Radiofrequency (RF) ablation has been the most widely assessed alternative to PEI. Five randomized controlled trials have shown that RF ablation achieves more effective and reproducible tumor destruction than PEI, leading to a better local control of the disease. As a result, RF ablation has been established as the primary ablative modality. The value of newer thermal and nonthermal methods for local tumor treatment, such as microwave ablation, irreversible electroporation (IRE), and light activated drug therapy, should be investigated in the setting of randomized controlled trials.

AB - Image-guided percutaneous ablation is currently accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when transplantation and resection are precluded. Several methods for chemical or thermal tumor destruction have been developed and tested clinically during the past two decades. The seminal technique used for local treatment of HCC has been percutaneous ethanol injection (PEI). Several studies have provided indirect evidence that PEI improves the natural history of nonsurgical patients with early-stage HCC. Its major limitation is the high rate of local recurrence. Radiofrequency (RF) ablation has been the most widely assessed alternative to PEI. Five randomized controlled trials have shown that RF ablation achieves more effective and reproducible tumor destruction than PEI, leading to a better local control of the disease. As a result, RF ablation has been established as the primary ablative modality. The value of newer thermal and nonthermal methods for local tumor treatment, such as microwave ablation, irreversible electroporation (IRE), and light activated drug therapy, should be investigated in the setting of randomized controlled trials.

KW - Hepatocellular carcinoma

KW - Percutaneous ethanol injection

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=79952112493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952112493&partnerID=8YFLogxK

U2 - 10.1007/s00534-009-0233-0

DO - 10.1007/s00534-009-0233-0

M3 - Article

C2 - 20091187

AN - SCOPUS:79952112493

VL - 17

SP - 399

EP - 403

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 4

ER -